Focus on the Heart and Aorta in Turner Syndrome

Journal of Pediatrics

Volumn 150, Issue 6, 2007, Pages 572-574

  Lin, Angela E ^a   Silberbach, Michael ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

AORTA DISEASE; AORTA DISSECTION; ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAM; HUMAN; MARFAN SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; SCREENING; SURGICAL RISK; TURNER SYNDROME;

ALGORITHMS; ANEURYSM, DISSECTING; AORTA; AORTA, ABDOMINAL; AORTA, THORACIC; AORTIC ANEURYSM; DISEASE PROGRESSION; HEART VENTRICLES; HUMAN GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; TURNER SYNDROME;

EID: 34248574424     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.03.038     Document Type: Editorial

References (14)

1. Matura L.A., Sachdev V., Bakalov V.K., Rosing D.R., and Bondy C.A. Growth hormone treatment and left ventricular dimensions in Turner syndrome. J Pediatr 150 (2007) 587-591
2. Sas T.C., Cromme-Dijkhuis A.H., de Muinck Keizer-Schrama S.M., Stijnen T., van Teunenbroek A., and Drop S.L. The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. J Pediatr 135 (1999) 470-476
3. Bondy C.A., Van P.L., Bakalov V.K., and Ho V.B. Growth hormone treatment and aortic dimensions in Turner syndrome. J Clin Endocrinol Metab 91 (2006) 1785-1788
4. Lin A.E., Lippe B., and Rosenfeld R.G. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 102 (1998) e12
5. Sybert V.P. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 101 (1998) e11
6. Gravholt C.H., Landin-Wilhelmsen K., Stochholm K., Hjerrild B.E., Ledet T., Djurhuus C.B., et al. Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol Young 16 (2006) 430-436
7. Ostberg J.E., Donald A.E., Halcox J.P., Storry C., McCarthy C., and Conway G.S. Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 90 (2005) 5161-5166
8. Pereira L., Andrikopoulos K., Tian J., Lee S.Y., Keene D.R., Ono R., et al. Targeting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet 17 (1997) 218-222
9. Loeys B.L., Schwarze U., Holm T., Callewaert B.L., Thomas G.H., Pannu H., et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355 (2006) 788-798
10. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
11. Carlson M, Silberbach M. Dissection of the aorta in Turner syndrome: Two new cases and review of 85 cases in the literature. (Submitted to Pediatrics).
12. Meszaros I., Morocz J., Szlavi J., Schmidt J., Tornoci L., Nagy L., et al. Epidemiology and clinicopathology of aortic dissection. Chest 117 (2000) 1271-1278
13. Silberbach M. Making treatment decisions for those with congenital heart disease in Turner syndrome: the need for evidence-based medicine. International Congress Series 1298 (2006) 131-136 (Eds. Bondy CA, Gravholt C, Elsevier)
14. Bondy C.A. Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab 92 (2007) 10-25